Inteliview
Log inSign up
IPO Tracker
L

Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics Inc.

US / NASDAQ CapitalListed
Valuation--
Listed DateApril 23, 2026
SectorN/A
ExchangeNASDAQ Capital
RELATED IPOS
G
General Catalyst Global Resilience Merger Corp.General Catalyst Global Resilience Merger Corp.N/A · $350M
Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc.Hemab Therapeutics Holdings, Inc.N/A · $302M
Avalyn Pharma Inc.
Avalyn Pharma Inc.Avalyn Pharma Inc.N/A · $300M
A
ARC Group Acquisition I Corp.ARC Group Acquisition I Corp.N/A · $105M
SILVER BOW MINING CORP.
SILVER BOW MINING CORP.SILVER BOW MINING CORP.N/A · $65M
M
Mountain Crest Acquisition 6 Corp.Mountain Crest Acquisition 6 Corp.N/A · $60M
FAQ

When is the Lakewood-Amedex Biotherapeutics Inc. IPO expected?

Lakewood-Amedex Biotherapeutics Inc. has already gone public. It listed on April 23, 2026.

Can retail investors participate in the Lakewood-Amedex Biotherapeutics Inc. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NASDAQ Capital after listing. Some brokerages offer IPO access programs for pre-IPO allocation.